Categories: Business

Embolx Launches Sniper G3: Revolutionizing Embolization with Enhanced Efficiency, Ease of Use, and Extended Shelf Life

SUNNYVALE, Calif., July 28, 2025 /PRNewswire/ — Embolx, a leader in advanced microcatheters for targeted embolization procedures, today announced the release of its next-generation Sniper G3 Balloon Occlusion Microcatheter. This third iteration of the innovative device delivers significant enhancements, including an extended shelf life, improved ease of use, and streamlined preparation, directly addressing critical feedback from physician users.

- Advertisement -

The highly anticipated Sniper G3 features a 24-month shelf life, doubling the longevity of its predecessor. This improvement offers greater inventory flexibility for hospitals and clinics. Designed with direct input from interventional radiologists, Sniper G3 also features improved trackability and a simplified preparation process, significantly reducing pre-procedure setup time. The new prep method eliminates several steps, cutting preparation time down to less than a minute, a crucial gain in fast-paced clinical environments. This focus on user feedback underscores Embolx’s commitment to developing intuitive, high-performance tools that enhance clinical workflow.

- Advertisement -

Sniper G3 truly exemplifies our dedication to innovation driven by physician needs,” said Michael Allen, President and CEO of Embolx. “We listened intently to our users and engineered a device that not only extends product longevity and improves performance, but also significantly enhances the ease of use, which translates directly to more efficient procedures. We are incredibly proud of Sniper G3 and its potential to set a new standard in embolization therapy.”

- Advertisement -

The Sniper G3 Balloon Occlusion Microcatheter represents a significant leap forward in Embolx’s commitment to physician-centric innovation. It is available in all standard lengths and is ready for worldwide distribution.

- Advertisement -

About Embolx
Embolx has pioneered advanced pressure-mediated delivery of therapeutics directly into cancerous tumors, prostates, and other anatomical structures and is dedicated to transforming healthcare through the development of innovative technologies.

- Advertisement -

For media inquiries, please contact:

- Advertisement -

Haley McGregor
Global Marketing and Sales Operations Manager
hmcgregor@embolx.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/2738641/Sniper_g3_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/embolx-launches-sniper-g3-revolutionizing-embolization-with-enhanced-efficiency-ease-of-use-and-extended-shelf-life-302514310.html

- Advertisement -
PRNW Agency

Recent Posts

Updated IOC report shows 86 per cent of all permanent Olympic venues still in use

23 October 2025 - An updated analysis of venues shows that 86 per cent of all…

3 hours ago

Mastering Management Education in Real-Time: The ICFAI Business School (IBS) Approach to Case-Based Learning

ICFAI Business School (IBS) with second largest CASE repository in their arsenal globally, empowers management…

3 hours ago

Singtel’s RE:AI Receives Frost & Sullivan’s 2025 Southeast Asia Competitive Strategy Leadership Recognition for Excellence in GPU-as-a-Service Innovation

By integrating compute, connectivity, applications and orchestration, RE:AI sets new standards for AI infrastructure excellence…

3 hours ago

Sting is Writing the Playbook for New Age Marketing

In a landscape overrun with visual noise and fleeting attention, Sting Energy is flipping the…

6 hours ago

Manu Tyagi Unveils "Ruby Studios" with a Upcoming film Title "AUGUST KRANTI"

Founded by visionary producer Manu Tyagi, VM Music is committed to revolutionizing the music sector…

6 hours ago

Joget Unlocks Autonomous Productivity Across HR, Procurement, Customer Service, and Supply Chain with No-Code AI Agent Builder

Joget AI Agent Builder enables teams across every department to create goal-driven agents that execute…

6 hours ago